** = Publications listed in SCI/SSCI/Pubmed
** Woltsche, J; Pacher-Deutsch, C; Fürst, S; Gulden, L; Schwarzl, J; Feldbacher, N; Nepel, M; Celcer, L; Hasl, N; Rieper, V; Stadlbauer, V; Horvath, A
Microbial Dysbiosis in the Urinary Microbiome of Patients with Cirrhosis.
Am J Gastroenterol. 2025;
Doi: 10.14309/ajg.0000000000003634
PubMed
FullText
FullText_MUG
** Woltsche, J; Pacher-Deutsch, C; Feldbacher, N; Nepel, M; Fürst, S; Gulden, L; Schwarzl, J; Horvath, A; Stadlbauer, V
Urinary microbiome alterations in patients with cirrhosis: a link to an increased urinary tract infection risk
J HEPATOL. 2025; 82:
Web of Science
** Fürst, S; Traub, J; Schwarzl, J; Gulden, L; Woltsche, J; Horvath, A; Stadlbauer, V
Validation of an easy-to-use malnutrition screening in cirrhosis to predict outcome
J HEPATOL. Abstracts. 2024; 80: S229-S229.-EASL Congress; JUN 5-8, 2024; Milan, ITALY.
[Poster]
Web of Science
** Haller, R; Fürst, S; Woltsche, J; Gulden, L; Schwarzl, J; Traub, J; Feldbacher, N; Aliwa, B; Madl, T; Fauler, G; Horvath, A; Stadlbauer, V
Phascolarctobacterium as a predictor for survival in cirrhotic patients
J HEPATOL. 2023; 78: S354-S354.
[Poster]
Web of Science